⑴主要用于具有5q缺失细胞遗传学异常的骨髓增生异常综合征所致的输血依赖性贫血患者的治疗。⑵与地塞米松合用治疗已经接受过至少一种疗法的多发性骨髓瘤(套细胞淋巴瘤(MCL))患者。
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.